All stocks today
71229 stocks real-time data.
All stocks today

Stock quotes

Stock market live

Historical stock prices

Stocks market capitalization

Dividend stocks

Stock earnings

Stock revenue

Stock ratings. Where to invest?

NexgenRx Inc. revenue reports

NexgenRx Inc. financial reports, NexgenRx Inc. annual revenue in 2024. When does NexgenRx Inc. report revenue?
Add to widgets
Added to widgets

NexgenRx Inc. total revenue, net income and dynamics of changes in Canadian dollar today

Net revenue NexgenRx Inc. is now 2 803 332 $. Information about net revenue is taken from open sources. The dynamics of NexgenRx Inc. net income went down. The change was -480 086 $. These are the main financial indicators of NexgenRx Inc.. The financial schedule of NexgenRx Inc. consists of three charts of the main financial indicators of the company: total assets, net revenue, net income. The financial report on the chart of NexgenRx Inc. allows you to clearly see the dynamics of fixed assets. The value of the "total revenue of NexgenRx Inc." on the chart is marked in yellow.

Report date Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and Change (%)
Comparing current quartal report this year to quartal report last year.
31/03/2021 2 803 332 $ +17.64 % ↑ 362 111 $ +235.36 % ↑
31/12/2020 2 640 600 $ +5.48 % ↑ 842 197 $ +357.59 % ↑
30/09/2020 2 651 810 $ +18.53 % ↑ 509 843 $ -
30/06/2020 2 405 239 $ +1.94 % ↑ 479 104 $ -
30/09/2019 2 237 249 $ - -218 718 $ -
30/06/2019 2 359 578 $ - -34 938 $ -
31/03/2019 2 382 913 $ - 107 977 $ -
31/12/2018 2 503 323 $ - 184 049 $ -
Show:
to

NexgenRx Inc. financial report charts

The latest dates of NexgenRx Inc. financial statements available online: 31/12/2018, 31/12/2020, 31/03/2021. Dates and dates of financial statements are established by the laws of the country where the company operates. The current date of the financial report of NexgenRx Inc. for today is 31/03/2021. Gross profit NexgenRx Inc. is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services. Gross profit NexgenRx Inc. is 2 328 029 $

NexgenRx Inc. quarterly report dates

Cost of revenue NexgenRx Inc. is the total cost of producing and distributing of products and services of a company. Cost of revenue NexgenRx Inc. is 475 303 $ Total revenue NexgenRx Inc. refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods. Total revenue NexgenRx Inc. is 2 803 332 $ Operating income NexgenRx Inc. is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income NexgenRx Inc. is 392 311 $

Net income NexgenRx Inc. is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income NexgenRx Inc. is 362 111 $ Current assets NexgenRx Inc. is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets NexgenRx Inc. is 20 986 360 $ Total assets NexgenRx Inc. refers to the total amount of assets owned by a person or entity. Total assets NexgenRx Inc. is 27 776 338 $

31/03/2021 31/12/2020 30/09/2020 30/06/2020 30/09/2019 30/06/2019 31/03/2019 31/12/2018
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
2 328 029 $ 2 156 815 $ 2 360 682 $ 2 127 297 $ 1 961 541 $ 2 063 554 $ 2 096 039 $ 2 201 319 $
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
475 303 $ 483 785 $ 291 128 $ 277 942 $ 275 708 $ 296 024 $ 286 874 $ 302 004 $
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
2 803 332 $ 2 640 600 $ 2 651 810 $ 2 405 239 $ 2 237 249 $ 2 359 578 $ 2 382 913 $ 2 503 323 $
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
- - - - 2 237 249 $ 2 359 578 $ 2 382 913 $ 2 503 323 $
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
392 311 $ 182 023 $ 576 435 $ 548 242 $ -124 629 $ 19 767 $ 160 208 $ 217 774 $
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
362 111 $ 842 197 $ 509 843 $ 479 104 $ -218 718 $ -34 938 $ 107 977 $ 184 049 $
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
- - - - - - - -
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
2 411 021 $ 2 458 577 $ 2 075 375 $ 1 856 997 $ 2 361 878 $ 2 339 811 $ 2 222 705 $ 2 285 549 $
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
20 986 360 $ 18 374 274 $ 20 846 580 $ 19 829 035 $ 11 975 457 $ 11 832 040 $ 12 948 410 $ 12 353 676 $
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
27 776 338 $ 25 244 783 $ 27 521 761 $ 26 431 950 $ 18 705 593 $ 18 490 613 $ 19 525 323 $ 18 022 756 $
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
413 025 $ 801 965 $ 839 078 $ 824 926 $ 458 275 $ 616 143 $ 675 310 $ 833 658 $
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
- - - - 12 558 944 $ 13 382 106 $ 14 398 741 $ 13 828 536 $
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
- - - - - - - -
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
- - - - 16 832 275 $ 16 444 840 $ 17 492 154 $ 16 065 594 $
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
- - - - 89.99 % 88.94 % 89.59 % 89.14 %
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
4 411 971 $ 3 971 522 $ 3 181 612 $ 2 649 884 $ 1 873 318 $ 2 045 773 $ 2 033 169 $ 1 957 162 $
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
- - - - 278 362 $ 240 934 $ 95 645 $ 394 898 $

Last revenue report of NexgenRx Inc. was 31/03/2021. According to last financial report total revenue in NexgenRx Inc. was 2 803 332 Canadian dollar and changed by +17.64% since last year. Net income in NexgenRx Inc. was 362 111 $ in last quartal, net income changes to +235.36%.

Current cash NexgenRx Inc. - the sum of all of the cash a company has on the date of report. Current cash NexgenRx Inc. is 413 025 $

NexgenRx Inc. stocks data

NexgenRx Inc. financials